av/larimar-therapeutics--big.svg

COM:LARIMARTX

Larimar Therapeutics

  • Stock

USD

Last Close

6.13

22/11 21:00

Market Cap

584.11M

Beta: -

Volume Today

402.09K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
311K
-
gross profit
-311K
-
selling and marketing expenses
general and administrative expenses
8.14M
-
19.20M
135.78%
18.29M
4.72%
12.16M
33.51%
13.19M
8.50%
2.42M
81.63%
11.40M
370.17%
12.07M
5.90%
12.28M
1.72%
selling general and administrative expenses
8.14M
-
19.20M
135.78%
18.29M
4.72%
12.16M
33.51%
13.19M
8.50%
2.42M
81.63%
11.40M
370.17%
12.07M
5.90%
12.28M
1.72%
14.09M
14.76%
research and development expenses
27.39M
-
54.62M
99.40%
39.94M
26.88%
40.84M
2.26%
47.93M
17.36%
20.79M
56.62%
31.41M
51.07%
38.40M
22.25%
24.25M
36.84%
27.36M
12.82%
other expenses
82K
-
322K
292.68%
-171K
153.11%
1.17M
784.80%
cost and expenses
35.53M
-
73.81M
107.74%
58.23M
21.12%
53.00M
8.98%
61.12M
15.33%
23.21M
62.02%
42.80M
84.39%
50.47M
17.90%
36.53M
27.62%
41.76M
14.32%
operating expenses
35.53M
-
73.81M
107.74%
58.23M
21.12%
53.00M
8.98%
61.12M
15.33%
23.21M
62.02%
42.80M
84.39%
50.47M
17.90%
36.53M
27.62%
41.45M
13.47%
interest expense
-870K
-
-473K
45.63%
347K
173.36%
971K
179.83%
-246K
125.33%
-1.77M
617.89%
-318K
-
ebitda
-35.53M
-
-74.69M
110.20%
-57.32M
23.26%
-50.87M
11.25%
-61.35M
20.61%
-23.14M
62.29%
-42.80M
85.01%
-50.47M
17.90%
-36.53M
27.62%
-41.45M
13.47%
operating income
-35.53M
-
-73.81M
107.74%
-58.23M
21.12%
-53.00M
8.98%
-61.12M
15.33%
-23.21M
62.02%
-42.80M
84.39%
-50.47M
17.90%
-36.53M
27.62%
-41.76M
14.32%
depreciation and amortization
70K
-
212K
202.86%
188K
11.32%
261K
38.83%
78K
70.11%
155K
98.72%
326K
110.32%
318K
2.45%
311K
2.20%
total other income expenses net
-1.04M
-
-473K
54.43%
347K
173.36%
971K
179.83%
-246K
125.33%
82K
133.33%
322K
292.68%
-171K
153.11%
1.17M
784.80%
4.81M
310.67%
income before tax
-36.57M
-
-74.29M
103.13%
-57.88M
22.09%
-52.03M
10.11%
-61.37M
17.95%
-23.13M
62.31%
-42.48M
83.65%
-50.64M
19.19%
-35.35M
30.18%
-36.95M
4.51%
income tax expense
-946K
-
694K
173.36%
1.94M
179.83%
-492K
125.33%
-155K
-
-326K
110.32%
-1.17M
259.20%
net income
-36.57M
-
-74.29M
103.13%
-57.88M
22.09%
-52.03M
10.11%
-61.37M
17.95%
-23.13M
62.31%
-42.33M
82.98%
-50.31M
18.86%
-34.18M
32.05%
-36.95M
8.09%
weighted average shs out
12.19B
-
2.23M
99.98%
2.27M
2.03%
2.29M
0.50%
2.69M
17.48%
9.21M
243.08%
11.88M
28.97%
17.16M
44.44%
25.76M
50.09%
43.90M
70.41%
weighted average shs out dil
12.19B
-
2.23M
99.98%
2.27M
2.03%
2.29M
0.50%
2.69M
17.48%
9.21M
243.08%
11.88M
28.97%
17.16M
44.44%
25.76M
50.09%
43.90M
70.41%
eps
-0.00
-
-33.32
1,110,566.67%
-25.44
23.65%
-22.76
10.53%
-22.85
0.40%
-2.51
89.02%
-3.56
41.83%
-2.93
17.70%
-1.33
54.61%
-0.84
36.84%
epsdiluted
-0.00
-
-33.32
1,110,566.67%
-25.44
23.65%
-22.76
10.53%
-22.85
0.40%
-2.51
89.02%
-3.56
41.83%
-2.93
17.70%
-1.33
54.61%
-0.84
36.84%

All numbers in USD (except ratios and percentages)